TEVA - US TevTropin® 10mg SNDA
TEVA Vibex™ EPI ANDA
TEVA Vibex™ Sumatriptan ANDA
The company has three drugs waiting for FDA approvals and one to file near term. On one TEVA approval it will get a milestone payment. Now that Otrexup is approved in the U.S, it can now apply to other countries for approval. We also have the launch near term..
I think some are controlling the price to let the $5 calls expire worthless for Oct and Nov. This price action may not impact investors much who bought under $5. Those call buyers tried to be smart by buying calls and not the underlying stock. Now the call writers are rendering them worthless. The forward data for this company looks for pretty good for investors with a over 12 to 18 month investment time horizon.